INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Dec 10, 2021 |
EVP Research and Development
Trans History: 618
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| Dec 10, 2021 |
Director
Trans History: 705
|
Director | Other acquisition or disposition | -- | -- |
| Dec 10, 2021 |
Director
Trans History: 705
|
Director | Other acquisition or disposition | -- | -- |
| Dec 10, 2021 |
Director
Trans History: 705
|
Director | Other acquisition or disposition | -- | -- |
| Dec 08, 2021 |
EVP Research and Development
Trans History: 618
|
EVP Research and Development | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,926 | -- |
| Dec 08, 2021 |
EVP Research and Development
Trans History: 618
|
EVP Research and Development | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,494 | -- |
| Dec 08, 2021 |
Director
Trans History: 705
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,861 | -- |
| Dec 08, 2021 |
Director
Trans History: 705
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,198 | -- |
| Dec 02, 2021 |
EVP Commercial
Trans History: 54
|
EVP Commercial | Other acquisition or disposition | -- | -- |
| Dec 01, 2021 |
EVP Commercial
Trans History: 54
|
EVP Commercial | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,000 | $342.93 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.